This company has been marked as potentially delisted and may not be actively trading. NASDAQ:VTL Vital Therapies (VTL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Vital Therapies Stock (NASDAQ:VTL) 30 days 90 days 365 days Advanced Chart Get Vital Therapies alerts:Sign Up Key Stats Today's Range$0.83▼$0.9450-Day Range$0.83▼$14.5052-Week Range$0.15▼$9.75Volume1.06 million shsAverage Volume21.62 million shsMarket Capitalization$36.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA. Read More Receive VTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter. Email Address VTL Stock News Headlines18,000 vulnerable children could lose ‘vital’ therapy as adoption fund faces axeMarch 31, 2025 | msn.comVeterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And HealingNovember 11, 2024 | benzinga.com#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opportunity is taking shape—one tied to what could be the largest IPO in history: Elon Musk’s Starlink. With the IPO rumored to launch as soon as this year, James has uncovered a backdoor method to potentially profit before it goes public—starting with as little as $50.August 10 at 2:00 AM | Paradigm Press (Ad)Lighthouse Center for Vital Living celebrates new buildingOctober 30, 2024 | duluthnewstribune.comDVital Care Receives Strategic Investment From Berkshire Partners, Leonard Green & Partners, and Linden Capital PartnersAugust 1, 2024 | tmcnet.comVeterans lobbied for psychedelic therapy, but it may not be enough to save MDMA drug applicationJuly 26, 2024 | msn.comVardhman Textiles Ltd.May 22, 2024 | wsj.comVital Spa celebrates a year on Bridge StreetApril 28, 2024 | yahoo.comSee More Headlines VTL Stock Analysis - Frequently Asked Questions How were Vital Therapies' earnings last quarter? Vital Therapies, Inc. (NASDAQ:VTL) posted its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.03. What other stocks do shareholders of Vital Therapies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Bristol Myers Squibb (BMY), Novavax (NVAX) and Viking Therapeutics (VKTX). Company Calendar Last Earnings8/07/2018Today8/10/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:VTL CIK1280776 Webvitaltherapies.com Phone(858) 673-6840FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$41.47 million Net MarginsN/A Pretax MarginN/A Return on Equity-235.33% Return on Assets-182.35% Debt Debt-to-Equity RatioN/A Current Ratio6.97 Quick Ratio6.97 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.29 per share Price / Book3.01Miscellaneous Outstanding Shares42,370,000Free FloatN/AMarket Cap$36.95 million OptionableNot Optionable Beta3.51 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:VTL) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vital Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vital Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.